US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
カナダ
TSXV
Waverley Pharma Inc (WAVE)
Waverley Pharma Inc (WAVE) ニュース

WAVE

Waverley Pharma (WAVE)

Waverley Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:WAVE

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/01	09 : 08	PR Newswire (Canada)	Waverley Pharma Business Update	TSXV:WAVE	Waverley Pharma Inc
2023/11/23	07 : 00	PR Newswire (Canada)	Waverley Pharma Announces Changes to Board of Directors	TSXV:WAVE	Waverley Pharma Inc
2023/08/03	05 : 37	PR Newswire (Canada)	Waverley Pharma Business Update	TSXV:WAVE	Waverley Pharma Inc
2023/03/20	20 : 55	PR Newswire (Canada)	Waverley Pharma Provides Business Update	TSXV:WAVE	Waverley Pharma Inc
2023/01/11	21 : 55	PR Newswire (Canada)	Waverley Pharma Provides Update on its PARP-1 Inhibitor Program	TSXV:WAVE	Waverley Pharma Inc
2021/08/05	21 : 05	PR Newswire (Canada)	Waverley Pharma Announces $3,000,000 Credit Facility	TSXV:WAVE	Waverley Pharma Inc
2021/05/27	21 : 05	PR Newswire (Canada)	Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS England	TSXV:WAVE	Waverley Pharma Inc
2021/01/18	22 : 40	PR Newswire (Canada)	Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS Scotland	TSXV:WAVE	Waverley Pharma Inc
2020/11/13	02 : 04	PR Newswire (Canada)	Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United States	TSXV:WAVE	Waverley Pharma Inc
2020/09/23	21 : 20	PR Newswire (Canada)	Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)	TSXV:WAVE	Waverley Pharma Inc
2020/09/08	23 : 13	PR Newswire (Canada)	Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the Un...	TSXV:WAVE	Waverley Pharma Inc
2020/08/25	21 : 15	PR Newswire (Canada)	Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in Italy	TSXV:WAVE	Waverley Pharma Inc
2020/07/30	21 : 25	PR Newswire (Canada)	Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries	TSXV:WAVE	Waverley Pharma Inc
2020/06/25	21 : 15	PR Newswire (Canada)	Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Syn...	TSXV:WAVE	Waverley Pharma Inc
2020/04/29	05 : 53	PR Newswire (Canada)	Waverley Pharma Announces Reliance on Relief from Filing Requirements for Annual Financial Statements	TSXV:WAVE	Waverley Pharma Inc
2020/02/03	22 : 15	PR Newswire (Canada)	Waverley Pharma Announces Appointment of New President and CEO	TSXV:WAVE	Waverley Pharma Inc
2020/01/09	07 : 09	PR Newswire (Canada)	Waverley Pharma Announces Executive Leadership Changes	TSXV:WAVE	Waverley Pharma Inc
2019/12/17	22 : 00	PR Newswire (Canada)	Waverley Pharma Announces Grant of Marketing Authorization in the United Kingdom for Erlotinib	TSXV:WAVE	Waverley Pharma Inc
2019/03/11	21 : 25	PR Newswire (Canada)	Waverley Pharma Provides Market Update and Fiscal 2018 Preliminary Revenue	TSXV:WAVE	Waverley Pharma Inc
2018/12/18	22 : 25	PR Newswire (Canada)	Waverley Pharma Announces Distribution Agreement and First Sale of Generic Oncology Products in the United Kingdom	TSXV:WAVE	Waverley Pharma Inc
2018/07/23	21 : 35	PR Newswire (Canada)	Waverley Pharma Announces Resignation of CEO and Appointment of New CEO	TSXV:WAVE	Waverley Pharma Inc
2018/06/27	21 : 35	PR Newswire (Canada)	Waverley Pharma Announces Filing of Two Abbreviated New Drug Applications in the United States	TSXV:WAVE	Waverley Pharma Inc
2018/06/25	21 : 30	PR Newswire (Canada)	Waverley Pharma Announces Acquisition of two Generic Oncology Products Currently Marketed in the United Kingdom	TSXV:WAVE	Waverley Pharma Inc
2018/04/17	21 : 30	PR Newswire (Canada)	Waverley Pharma Announces Filing of its Second Marketing Authorization Application in Select European Union Countries	TSXV:WAVE	Waverley Pharma Inc
2018/03/12	22 : 00	PR Newswire (Canada)	Waverley Pharma Announces Filing of Marketing Authorization Application in Select European Union Countries	TSXV:WAVE	Waverley Pharma Inc
2017/10/27	23 : 01	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - WAVE (anciennement BUFF.P)	TSXV:WAVE	Waverley Pharma Inc
2017/10/27	22 : 59	PR Newswire (Canada)	IIROC Trading Resumption - WAVE (Formerly BUFF.P)	TSXV:WAVE	Waverley Pharma Inc

Showing the most relevant articles for your search:TSXV:WAVE

1

US Dollar vs Sterling

BNP Paribas (QX)

JP Morgan Chase

Verizon Communications

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約